---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-015037"
form_type: "8-K"
ticker: "SER"
cik: "0001708599"
company_name: "Serina Therapeutics, Inc."
filed_at: "2024-04-17T23:59:59+00:00"
generated_at: "2026-06-03T21:44:29.109595+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Serina Therapeutics appoints Dr. Simba Gill as Executive Chairman

## Summary
- Dr. Simba Gill appointed Executive Chairman effective April 12, 2024.
- Annual cash fee of $300,000 and grant of 295,300 stock options under 2024 Equity Incentive Plan.
- Dr. Gill has over 35 years of biotech leadership including Maxygen, Systemix, Boehringer Mannheim, Celltech.
- Five-year post-termination non-compete and non-solicitation covenants apply.

## SEC filing metadata
- accession: 0001493152-24-015037
- form_type: 8-K
- ticker: SER
- cik: 0001708599
- company_name: Serina Therapeutics, Inc.
- filed_at: 2024-04-17T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1708599/000149315224015037/0001493152-24-015037-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1708599/000149315224015037/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-015037
- JSON: https://secwatch.observer/filing/0001493152-24-015037.json
- Plain text: https://secwatch.observer/filing/0001493152-24-015037.txt

## Key facts
- Executive change
  Simba Gill was appointed as Executive Chairman at Serina Therapeutics, Inc..
  - Action: appointed
  - Role: Executive Chairman
  source text: On April 17, 2024, Serina Therapeutics, Inc. (the “Company”) announced the appointment of Simba Gill, Ph.D., as the Company’s Chairman of the Board of Directors, effective as of April 12, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1708599/000149315224015037/0001493152-24-015037-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.